We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
IL-6: an early marker for outcome in acute ischemic stroke.
- Authors
Waje-Andreassen, U.; Kråkenes, J.; Ulvestad, E.; Thomassen, L.; Myhr, K.-M.; Aarseth, J.; Vedeler, C. A.
- Abstract
Waje-Andreassen U, Kråkenes J, Ulvestad E, Thomassen L, Myhr K-M, Aarseth J, Vedeler CA. IL-6: an early marker for outcome in acute ischemic stroke.Acta Neurol Scand 2005: 111: 360–365.© Blackwell Munksgaard 2005.Inflammation plays an important role in the pathophysiology of stroke. We correlated interleukin (IL)-6, IL-10, C-reactive protein (CRP) and T-lymphocyte subtype levels in acute ischemic stroke patients with stroke volume and clinical outcome.Blood samples were obtained from 11 patients at defined intervals during 1 year. Nine healthy age-matched subjects served as controls. IL-6, IL-10 and CRP were quantified by enzyme-linked immunosorbent assay and T lymphocytes by flow cytometry. Volume measurement was carried out by computed tomography or magnetic resonance imaging and clinical outcome was scored by the European stroke scale (ESS) and Barthel index (BI).IL-6 levels were increased in the acute phase of stroke compared with healthy controls (P = 0.002) and correlated with larger stroke volume (P = 0.012) and less favorable prognosis after 1 year, measured by ESS (P = 0.014) and BI (P = 0.006). IL-10, CRP and T-lymphocyte subtypes in the acute phase were not correlated with stroke volume or clinical outcome.IL-6 seems to be a robust early marker for outcome in acute ischemic stroke.
- Subjects
CEREBROVASCULAR disease patients; PATHOLOGICAL physiology; LYMPHOCYTES; ACUTE phase proteins; DIAGNOSTIC imaging; CYTOLOGY
- Publication
Acta Neurologica Scandinavica, 2005, Vol 111, Issue 6, p360
- ISSN
0001-6314
- Publication type
Article
- DOI
10.1111/j.1600-0404.2005.00416.x